Royal DSM NV has acquired 100% of Lipid Technologies Provider (LTP) AB, a Swedish company that develops lipid delivery systems for functional foods.

LTP’s most popular product is a satiety ingredient branded Olibra, which reduces calorie intake. According to DSM, satiety products are gaining in importance in the area of weight management.

“The acquisition of Lipid Technologies Provider fits seamlessly with DSM’s strategic drive, Vision 2010 – Building on Strengths, in which we focus on market driven growth and innovation, with nutrition being one of the main areas,” said Feike Sijbesma, member of DSM’s managing board.

Rob van Leen, DSM’s chief innovation officer, commented: “LTP and DSM are already researching new products and solutions in the area of weight management. This step, in combination with DSM’s other activities in this market, lays a broad foundation to create more innovative products that help consumers in changing their lifestyle towards a sustainably healthier life.”

DSM’s acquisition has been a long time in the making. DSM first invested in LTP in 2003, eventually taking a 27% stake in the company. In mid-2005 DSM and LTP entered into a global marketing and sales agreement, which gave DSM the exclusive right to market Olibra in the dairy foods market.

The company said that the EUR18m (US$22.86m) acquisition was a “natural step” given DSM’s strategic goal of increasing its presence in the health ingredients and weight management sectors. Moreover, the company said, LTP’s technology platform will support future opportunities for new applications, including outside the weight management category.